产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | HS 683 (人脑胶质瘤细胞) (STR鉴定正确) |
| 别称 | HS 683; HS-683; Hs-683; Hs683; HS683; Hs 683.T; HS 683T; Hs683T |
| 种属 | 人 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 成纤维细胞样 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养方案A（默认） |
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 1:2-1:4 |
| 推荐换液频率 | 2-3次/周 |
| 背景描述 | HS 683细胞源自76岁白人男性的左颞叶侧胶质瘤组织；HS 683细胞有微绒毛，无桥粒。 |
| 年龄（性别） | 男性；76岁 |
| 组织来源 | 脑组织 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 胶质瘤细胞 |
| 生物安全等级 | BSL-1 |
| 倍增时间 | ~49-96 hours |
| 致瘤性 | No, in immunosuppressed mice.Yes, in semisolid medium. |
| 保藏机构 | ATCC; HTB-138 |
STR鉴定
-
STR位点信息
Amelogenin X,Y CSF1PO 9,13 D2S1338 18,20 D3S1358 14,16 D5S818 11,12 D7S820 11 D8S1179 12,13 D13S317 8,12 D16S539 9,10 D18S51 12,14 D19S433 14 D21S11 27,33.2 FGA 21.2,22 PentaD 13,14 PentaE 13,15 TH01 6,8 TPOX 8,11 vWA 18,20 D6S1043 11,12 D12S391 17,20 D2S441 12,15 -
STR鉴定图
-
参考文献
-
Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics (2023-11-30)
作者：Bo Wang:1.Department of Neurosurgery, Zhongnan Hospital of Wuhan University, 430071 Wuhan, China; Brain Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China. ; Yu Feng:1.Department of Neurosurgery, Zhongnan Hospital of Wuhan University, 430071 Wuhan, China. ; Zhengwei Li:1.Department of Neurosurgery, Zhongnan Hospital of Wuhan University, 430071 Wuhan, China. ; Fan Zhou:1.Huanggang Central Hospital of Yangtze University, Hubei 438000, China. ; Jie Luo:1.Huanggang Central Hospital of Yangtze University, Hubei 438000, China. ; Bin Yang:1.Department of Neurosurgery, Zhongnan Hospital of Wuhan University, 430071 Wuhan, China; Brain Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China. ; Shengrong Long:1.Department of Neurosurgery, Zhongnan Hospital of Wuhan University, 430071 Wuhan, China; Brain Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China. ; Xinyi Li:1.Department of Neurosurgery, Zhongnan Hospital of Wuhan University, 430071 W
期刊：Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics
影响因子 ：6.1
引用产品： HS 683 细胞
-
Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction (2023-06-09)
作者：Huanyu Li:1.Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, Liaoning Province, China. ; 2.Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Key Laboratory of Precision Diagnosis and Treatment of GastrointestinalTumors (China Medical University), Ministry of Education, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Shenyang, 110122, Liaoning Province, China. ; Xiaoyu Sun:1.Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, Liaoning Province, China. ; 2.Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Key Laboratory of Precision Diagnosis and Treatment of GastrointestinalTumors (China Medical University), Ministry of Education, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Shenyang, 110122, Liaoning Province, China. ; Yanyun Zhao:1.Department of Pharmacology, Schoo
期刊：Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
DOI：10.1186/s12885-023-11015-w
影响因子 ：3.8
引用产品： HS 683 细胞
-
A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing (2022-08-30)
作者：Kai Guo:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; 2.Department of Neurosurgery, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China. ; Xinxin Duan:1.Department of Oncology, Hebei General Hospital, Shijiazhuang, China. ; 2.Graduate School, North China University of Science and Technology, Tangshan, China. ; Jiahui Zhao:1.Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. ; Boyu Sun:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Xiaoming Liu:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Zongmao Zhao:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ;
期刊：A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing
影响因子 ：6.1
引用产品： U-118 MG 细胞 , U138 细胞 , LN229 [LN-229; LNT-229] 细胞 , HS 683 细胞 , U-118 MG细胞专用培养基 , U138 细胞专用培养基 , LN229 [LN-229; LNT-229]细胞专用培养基 , HS 683细胞专用培养基
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
![NCI-H522[H522] (人非小细胞肺癌细胞) (STR鉴定正确)](/Public/upfile/pic/xbx/CL-0839-1.jpg)
